Millennium Management’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Millennium Management’s Portfolio PAND Stock Details PAND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-119,711	Closed	-$7.19M	–	7479
2021 Q1	$7.19M	Buy	119,711 +91,849	+330%	+$3.33M	0.01%	2165
2020 Q4	$414K	Sell	27,862 -178,067	-86%	-$2.48M	﹤0.01%	4347
2020 Q3	$2.36M	Buy	+205,929	New	+$3.52M	﹤0.01%	2475

Millennium Management's PAND Position: Q2 2021 in Review

Millennium Management sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 119,711 shares — an estimated $7.19M sold.

Millennium Management first reported a position in PAND in Q3 2020 and held it in 3 quarters. The position peaked at $7.19M in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

Millennium Management reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Millennium Management sold 119,711 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $7.19M.
Millennium Management first reported a position in Pandion Therapeutics Inc. Common Stock in Q3 2020 and held it in 3 quarters.
Millennium Management's Pandion Therapeutics Inc. Common Stock position peaked at $7.19M in Q1 2021.
0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Millennium Management's 13F filing for Q2 2021, filed 16 Aug 2021.